Co-diagnostics, inc. shares list of upcoming industry conferences and events for february 2024

Salt lake city , feb. 1, 2024 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the list of events it has chosen to exhibit at or participate in during february, 2024, and which strategically align with the company's vision. at each event, co-dx will discuss its upcoming at-home and point-of-care co-dx™ pcr platform technology*, which has been designed to bring pcr diagnostics to the point-of-care in the service of achieving the company's mission of increasing accessibility of affordable gold-standard pcr diagnostics around the world.
CODX Ratings Summary
CODX Quant Ranking